Načítá se...

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial

BACKGROUND: HPV FOCAL is a randomized trial (ISRCTN79347302, registered 20 Apr 2007) comparing high-risk (hr) HPV testing vs. liquid-based cytology (LBC) for cervical cancer screening of women aged 25–65. We compared the Digene Hybrid Capture® 2 High-Risk HPV DNA Test® (HC2) and the Roche cobas® 480...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	BMC Cancer
Hlavní autoři:	Cook, Darrel A., Mei, Wendy, Smith, Laurie W., van Niekerk, Dirk J., Ceballos, Kathy, Franco, Eduardo L., Coldman, Andrew J., Ogilvie, Gina S., Krajden, Mel
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BioMed Central 2015
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4682219/ https://ncbi.nlm.nih.gov/pubmed/26674353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1959-5
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo otaguje tento záznam!

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial

Podobné jednotky